RIVASUR 2x semaine patch 9,5 mg/24h 16 pc

7680688970074 CH-68897 N06DA03 01.99.0.

Active substances:

No images available

Details

Product number
6889702
CPT
-
Packaging group
16
Unit
Pflaster
Composition
I) (cerotto transdermico): rivastigminum 51.84 mg, E 307, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, butylis methacrylatis et methylis methacrylatis polymerisatum, polyisobutylenum, polybutylenum, materiale di supporto: poly(ethylenis terephthalas), polyethylenum, tinta: blu, ad praeparationem pro 21.6 cm², cum liberatione 9.5 mg/24h. II) (cerotto di copertura): acrylates et vinylis acetatis polymerisatum, materiale di supporto: polyesterum, ad praeparationem pro 46.7 cm².

Articles (1)

Rivasur due volte alla settimana 9,5 mg/24 ore, cerotto transdermico
Pflaster
16
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
11/08/2026
Professional SmPC
Français
11/08/2026
Professional SmPC
Italien
11/08/2026
Patient information leaflet
Allemand
18/06/2026
Patient information leaflet
Français
18/06/2026
Patient information leaflet
Italien
18/06/2026

Detailed composition

Substance Quantity Type Category
rivastigminum
51.84 MG Substance Wirkstoff (Principe actif)
acrylates et vinylis acetatis polymerisatum
- Substance HPFLA
E 307
- Substance ANTON
polyesterum
- Substance HNIDK
2-ethylhexylis acrylatis et vinylis acetatis polymerisatum
- Substance HNIDK
butylis methacrylatis et methylis methacrylatis polymerisatum
- Substance HNIDK
polyisobutylenum
- Substance HNIDK
polybutylenum
- Substance HNIDK
poly(ethylenis terephthalas)
- Substance HNIDK
polyethylenum
- Substance HNIDK

Reimbursement information

Public price
CHF 86.70
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2026

Authorization holder

Zambon Svizzera SA

6814 Cadempino

Authorization information

Swissmedic authorization number
68897
Drug name
Rivasur due volte alla settimana, cerotto transdermico
Galenic form
TRAP
ATC Code
N06DA03
Authorization status
Z
Dispensation category
B
First authorization
13/02/2024
Authorization expiration date
12/02/2029
IT number
01.99.0.
Domain
Human medicine
Field of application
Demenz vom Alzheimer-Typ

Packaging details

Description (FR)
RIVASUR 2x semaine patch 9,5 mg/24h 16 pc
Description (DE)
RIVASUR 2x Woche Patch 9,5 mg/24h 16 Stck
Market launch
27/04/2026
Narcotic (BTM)
No

Available generics

Rivastigmin-Mepha Patch, Transdermale Pflaster
CHF 54.05
View
Rivastigmin-Mepha Patch, Transdermale Pflaster
CHF 54.05
View
Rivastigmin-Mepha Patch, Transdermale Pflaster
CHF 91.70
View
Rivastigmin-Mepha Patch, Transdermale Pflaster
CHF 54.05
View
Rivastigmin-Mepha Patch, Transdermale Pflaster
CHF 91.70
View
Rivastigmin Patch Sandoz, Transdermales Pflaster
CHF 54.05
View
Rivastigmin Patch Sandoz, Transdermales Pflaster
CHF 54.05
View
Rivastigmin Patch Sandoz, Transdermales Pflaster
CHF 91.70
View
Rivastigmin Patch Sandoz, Transdermales Pflaster
CHF 54.05
View
Rivastigmin Patch Sandoz, Transdermales Pflaster
CHF 91.70
View

Other packaging sizes

RIVASUR 2x semaine patch 4,6 mg/24h 8 pc
8 PFLA
View
RIVASUR 2x semaine patch 4,6 mg/24h 16 pc
16 PFLA
View
RIVASUR 2x semaine patch 9,5 mg/24h 8 pc
8 PFLA
View
Buy us a coffee Explore the data